Serum COLL2-1 In Rheumatoid Arthritis: Its Relation to Disease Activity and Severity
Abdel-Monem, S., Soliman, A., Marei, M., Elwia, S., Fawzy, R. (2022). Serum COLL2-1 In Rheumatoid Arthritis: Its Relation to Disease Activity and Severity. EKB Journal Management System, 39(1), 235-246. doi: 10.21608/bmfj.2021.90025.1456
Samia Mohamed Abdel-Monem; Amal Fathy Soliman; Mohammed Moustafa Marei; Sania Khairy Elwia; Rasha Mohamed Fawzy. "Serum COLL2-1 In Rheumatoid Arthritis: Its Relation to Disease Activity and Severity". EKB Journal Management System, 39, 1, 2022, 235-246. doi: 10.21608/bmfj.2021.90025.1456
Abdel-Monem, S., Soliman, A., Marei, M., Elwia, S., Fawzy, R. (2022). 'Serum COLL2-1 In Rheumatoid Arthritis: Its Relation to Disease Activity and Severity', EKB Journal Management System, 39(1), pp. 235-246. doi: 10.21608/bmfj.2021.90025.1456
Abdel-Monem, S., Soliman, A., Marei, M., Elwia, S., Fawzy, R. Serum COLL2-1 In Rheumatoid Arthritis: Its Relation to Disease Activity and Severity. EKB Journal Management System, 2022; 39(1): 235-246. doi: 10.21608/bmfj.2021.90025.1456